These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 14664175

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Use of doxazosin (Cardura-Pfizer), alpha 1-adrenoreceptor antagonist, in treatment of hypertension in patients with diabetes].
    Grzeszczak W.
    Wiad Lek; 1998; 51 Suppl 2():5-10. PubMed ID: 9686527
    [Abstract] [Full Text] [Related]

  • 3. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 4. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y, Tsuchihashi T, Onaka U, Eto K, Ueno M.
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Antihypertensive therapy with doxazosin in patients with non-insulin-dependent diabetes mellitus].
    Lazebnik LB, Melichenko SB, Serebrov AN.
    Ter Arkh; 1998 Apr; 70(2):50-4. PubMed ID: 9551574
    [Abstract] [Full Text] [Related]

  • 7. Chronic alpha-1-adrenergic blockade increases sympathoneural but not adrenomedullary activity in patients with essential hypertension.
    Jacobs MC, Lenders JW, Willemsen JJ, Thien T.
    J Hypertens; 1995 Dec; 13(12 Pt 2):1837-41. PubMed ID: 8903663
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Misleading advertising claims about the indication of doxazosin (Cardura) for type 2 diabetes mellitus and hypertension].
    Hoogenberg K, van der Tuin J.
    Ned Tijdschr Geneeskd; 2002 Nov 02; 146(44):2099-100. PubMed ID: 12448967
    [Abstract] [Full Text] [Related]

  • 10. Doxazosin: safety and efficacy in the treatment of resistant arterial hypertension.
    Ceral J, Solar M.
    Blood Press; 2009 Nov 02; 18(1-2):74-7. PubMed ID: 19353415
    [Abstract] [Full Text] [Related]

  • 11. [Effects of monotherapy with an alpha1-adrenoblocker doxazosin and its combination with beta1-adrenoblocker atenolol on hemodynamics, reversible myocardial ischemia in postmyocardial infarction patients with arterial hypertension].
    Tepliakov AT, Gavrilova NV, Garganeeva AA.
    Klin Med (Mosk); 2003 Nov 02; 81(11):17-21. PubMed ID: 14689703
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Heart lines. Cardura update.
    Harv Heart Lett; 2001 Sep 02; 12(1):5-6. PubMed ID: 11572810
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of vardenafil on blood pressure profile of patients with erectile dysfunction concomitantly treated with doxazosin gastrointestinal therapeutic system for benign prostatic hyperplasia.
    Ng CF, Wong A, Cheng CW, Chan ES, Wong HM, Hou SM.
    J Urol; 2008 Sep 02; 180(3):1042-6. PubMed ID: 18639296
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.